PepsiCo gets more “Water”
This article was originally published in The Tan Sheet
Executive Summary
PepsiCo acquires V Water, a vitamin water brand launched in the U.K. in 2005 with six flavors. V Water, with ingredients including vitamin C, zinc, selenium and ginseng, provides PepsiCo "with a strong platform for expansion into a fast growing market, and reflects PepsiCo's global commitment to ... extending our range of healthier beverages," the firm says in an April 30 release. PepsiCo reached an exclusive bottling agreement with Britvic plc to manufacture, sell and distribute the V Water products in Great Britain. The purchase of V Water follows PepsiCo's recent announcement to acquire Russia's largest juice company, Lebedyansky, and the 2006 purchase of U.S.-based Naked Juice (1"The Tan Sheet" Nov. 27, 2006, In Brief)...
You may also be interested in...
PepsiCo gets Naked
The soft-drink giant continues adding brands targeted for health-conscious consumers with the acquisition of Naked Juice Company, which says it has achieved annual sales of more than $150 mil. primarily through grassroots marketing and sales efforts. Azusa, Calif.-based Naked, which was controlled by North Castle Partners private equity firm, produces more than 25 juice and juice-smoothie Naked selections made from fruits and nutritional boosts and without sugars or preservatives. The deal, with terms not disclosed, comes the same month PepsiCo launched Fuelosophy, a milk-based product with vitamins A, B, C, D and E that is being sold in test markets including some Whole Foods stores (1"The Tan Sheet" Nov. 20, 2006, In Brief). PepsiCo says nearly all of Naked's beverages qualify for the "Smart Spot designation" it has made for its more than 250 "products that contribute to a healthier lifestyle."...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.